Molecularly targeted immunotherapy used to treat a novel overlap syndrome of pediatric N‐methyl‐ d‐aspartate receptor encephalitis (NMDARE) and possible neurosarcoidosis

• Príomhchruthaitheoirí: Elizabeth Pickup (Údar), Christopher Redmond (Údar), Matthew A. Sherman (Údar), Lakshmi Ramachandran Nair (Údar), Sangeeta Sule (Údar), Elizabeth Wells (Údar), Alexandra B. Kornbluh (Údar)
• Formáid: LEABHAR
• Foilsithe / Cruthaithe: Wiley, 2024-06-01T00:00:00Z.
• Ábhair: article
• Rochtain ar líne: Connect to this object online.

Abstract Objective Overlap syndromes have been described between N‐methyl‐ d‐aspartate receptor encephalitis (NMDARE) and other neuroinflammatory conditions, although rarely involving neurosarcoidosis. Molecularly targeted immunotherapy may be helpful in the empiric treatment of these conditions. Me...